Literature DB >> 8801281

Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis.

M Rösener1, H Hahn, M Kranz, J Heeney, A Rethwilm.   

Abstract

Foamy virus (FV) infection has been implicated in the pathogenesis of sporadic motor neuron disease (MND) by means of serological assays. To confirm these results we tested serum and cerebrospinal fluid (CSF) samples from 23 cases of clinically verified non-familial MND and 11 cases of suspected non-familial MND for the presence of FV infection as determined by Western blot (WB) and indirect immunofluorescence assay (IFA). Using the same tests we also screened sera from 87 healthy chimpanzees for the presence of FV antibodies. None of the human samples in question tested positive. However, the testing revealed that 84 of 87 chimpanzees (96.6%) were seropositive for FV, indicating that combined WB and IFA are suitable methods for the serodiagnosis of FV infection. Given these results an association of FV infection and sporadic MND is highly improbable. Furthermore a suggested therapeutic trial with anti-retroviral drugs appears unjustified.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8801281     DOI: 10.1002/(SICI)1096-9071(199603)48:3<222::AID-JMV2>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging.

Authors:  M Heinkelein; J Thurow; M Dressler; H Imrich; D Neumann-Haefelin; M O McClure; A Rethwilm
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Identification and functional characterization of Bet protein as a negative regulator of BFV3026 replication.

Authors:  Tiejun Bing; Kai Wu; Xiaoxu Cui; Peng Shao; Qicheng Zhang; Xiaobo Bai; Juan Tan; Wentao Qiao
Journal:  Virus Genes       Date:  2014-03-11       Impact factor: 2.332

3.  Simian foamy virus isolated from an accidentally infected human individual.

Authors:  M Schweizer; V Falcone; J Gänge; R Turek; D Neumann-Haefelin
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

Review 4.  Historical perspective of foamy virus epidemiology and infection.

Authors:  C D Meiering; M L Linial
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 5.  Motor neuron-immune interactions: the vicious circle of ALS.

Authors:  Ana G Barbeito; Pinar Mesci; Séverine Boillée
Journal:  J Neural Transm (Vienna)       Date:  2010-06-15       Impact factor: 3.575

Review 6.  Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis.

Authors:  Wenxue Li; Darshan Pandya; Nicholas Pasternack; Marta Garcia-Montojo; Lisa Henderson; Christine A Kozak; Avindra Nath
Journal:  Neurotherapeutics       Date:  2022-04-12       Impact factor: 6.088

Review 7.  Retroviruses and amyotrophic lateral sclerosis.

Authors:  Tariq Alfahad; Avindra Nath
Journal:  Antiviral Res       Date:  2013-05-23       Impact factor: 5.970

Review 8.  A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis.

Authors:  Georgios Pampalakis; Georgios Angelis; Eleni Zingkou; Kostas Vekrellis; Georgia Sotiropoulou
Journal:  Clin Transl Med       Date:  2022-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.